Companies › TNDM

TANDEM DIABETES CARE INC COM NEW (TNDM)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001438133 · EDGAR filings · Updated 2026-07-17

TANDEM DIABETES CARE INC COM NEW (TNDM) has reported institutional ownership of 114.8%, with 273 institutional managers holding positions valued at $1.51B per the latest 13F reporting period.

Latest updates

• 2026-07-17 — Insider transaction reported (Form 4)
• 2026-06-17 — Notice of proposed sale filed (Form 144)
• 2026-06-04 — Insider transaction reported (Form 4)
• 2026-06-02 — Insider transaction reported (Form 4)
• 2026-06-02 — Insider transaction reported (Form 4)
• 2026-06-02 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, TANDEM DIABETES CARE INC COM NEW has 273 institutional holders and institutional ownership of 114.8%.

Insider activity

Insiders reported 180 transactions (2 buys, 2 sells) across 17 reporting insiders, with a net reported value of $247.4K.

Related companies

OLEMA PHARMACEUTICALS INC (OLMA) · PACS GROUP (PACS) · ORIC PHARMACEUTICALS INC (ORIC) · DEFINIUM THERAPEUTICS F (DFTX) · ATRICURE INC (ATRC) · DAMORA THERAPEUTICS INC (DMRA)